SM patients exhibited a slightly higher mean FET value (1.87 ± 0.284) than MCAS patients (1.65 ± 0.389), but the difference did not reach statistical significance ( P = 0.155; Figure 1 A).
← all excerpts
Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.
1
0.1550
0.1550